Heart transplantation: Difference between revisions
Jump to navigation
Jump to search
(/* Cardiac Transplantation (DO NOT EDIT) {{cite journal| author=Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM | display-authors=etal| title=2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | journal=Circulation | year= 2022 | volume= 145 | issue= 18 | pages= e876-e894 | pmid=35363500 | doi=10.1161/CIR.000000000000106...) |
|||
| Line 64: | Line 64: | ||
|- | |- | ||
|bgcolor="White"|<nowiki>"</nowiki>'''2.''' In [[patients] with stage D (advanced) [[HF]] despite GDMT, [[cardiac transplantation]] provides intermediate economic value. <ref name="pmid24563450">{{cite journal| author=Long EF, Swain GW, Mangi AA| title=Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure. | journal=Circ Heart Fail | year= 2014 | volume= 7 | issue= 3 | pages= 470-8 | pmid=24563450 | doi=10.1161/CIRCHEARTFAILURE.113.000807 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24563450 }} </ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | |bgcolor="White"|<nowiki>"</nowiki>'''2.''' In [[patients] with stage D (advanced) [[HF]] despite GDMT, [[cardiac transplantation]] provides intermediate economic value. <ref name="pmid24563450">{{cite journal| author=Long EF, Swain GW, Mangi AA| title=Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure. | journal=Circ Heart Fail | year= 2014 | volume= 7 | issue= 3 | pages= 470-8 | pmid=24563450 | doi=10.1161/CIRCHEARTFAILURE.113.000807 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24563450 }} </ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | ||
|} | |||
==Follow-Up== | ==Follow-Up== | ||
Revision as of 23:56, 22 June 2022
 |
Resident Survival Guide |
|
Heart transplantation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Heart transplantation On the Web |
|
American Roentgen Ray Society Images of Heart transplantation |
For patient information, click here
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D.; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [1]; Ifrah Fatima, M.B.B.S[2]
Synonyms and keywords: Cardiac transplantation; Heart grafting
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Prognosis
Diagnosis
There is no single diagnostic study of choice. A thorough evaluation should be done- including a physical examination and appropriate imaging to select the patients for a heart transplant. The indications and criteria should be fulfilled; the contraindications should be looked out for.
Indications
Contraindications
Criteria for Cardiac Transplantation
Equitable Distribution of Donor Hearts to those Awaiting Transplantation and the Process of Being Listed for a Transplant
Treatment
Medical Therapy
Surgery
Cardiac Transplantation (DO NOT EDIT) [1][2][3][4]
| Class I |
| "1. For selected patients with advanced HF despite GDMT, cardiac transplantation is indicated to improve survival and QOL. [5][6][7] (Level of Evidence: C-LD) " |
| Value Statement: Intermediate Value |
| "2. In [[patients] with stage D (advanced) HF despite GDMT, cardiac transplantation provides intermediate economic value. [8] (Level of Evidence: C-LD) " |
Follow-Up
Arrhythmias after transplantation
Electrocardiogram and Pacing After Cardiac Transplantation
Related Chapters
- ↑ Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM; et al. (2022). "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". Circulation. 145 (18): e876–e894. doi:10.1161/CIR.0000000000001062. PMID 35363500 Check
|pmid=value (help). - ↑ Yancy CW, Jessup M, Bozkurt B, Masoudi FA, Butler J, McBride PE; et al. (2013). "2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". J Am Coll Cardiol. doi:10.1016/j.jacc.2013.05.019. PMID 23747642.
- ↑ Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG et al. (2009)2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (14):1977-2016.DOI:10.1161/CIRCULATIONAHA.109.192064 PMID: 19324967
- ↑ Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (12):e154-235. DOI:10.1161/CIRCULATIONAHA.105.167586 PMID: 16160202
- ↑ Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D, Hsich E; et al. (2019). "The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match". J Heart Lung Transplant. 38 (10): 1056–1066. doi:10.1016/j.healun.2019.08.004. PMC 6816343 Check
|pmc=value (help). PMID 31548031. - ↑ Colvin M, Smith JM, Hadley N, Skeans MA, Uccellini K, Goff R; et al. (2020). "OPTN/SRTR 2018 Annual Data Report: Heart". Am J Transplant. 20 Suppl s1: 340–426. doi:10.1111/ajt.15676. PMID 31898418.
- ↑ Teuteberg JJ, Cleveland JC, Cowger J, Higgins RS, Goldstein DJ, Keebler M; et al. (2020). "The Society of Thoracic Surgeons Intermacs 2019 Annual Report: The Changing Landscape of Devices and Indications". Ann Thorac Surg. 109 (3): 649–660. doi:10.1016/j.athoracsur.2019.12.005. PMID 32115073 Check
|pmid=value (help). - ↑ Long EF, Swain GW, Mangi AA (2014). "Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure". Circ Heart Fail. 7 (3): 470–8. doi:10.1161/CIRCHEARTFAILURE.113.000807. PMID 24563450.